-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

711.P1.27 711. Cell Collection and Processing: Poster I

Cell Collection and Processing Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A, Level 2 (Orange County Convention Center)

Helmuth Schmidt, MD1, Johannes Schetelig2,3*, Karin Buhrmann, MD1*, Anna Kozlova1*, Gero Hütter, MD4*, Gerhard Ehninger, MD5 and Michael Punzel, MD1*

1Cellex GmbH, Cologne, Germany
2University Hospital Carl Gustav Carus, Dresden, Germany
3DKMS, German Bone Marrow Center, Dresden, Germany
4Cellex GmbH, Dresden, Germany
5Medical Department I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany

Mateusz Adamiak, MS1*, Agata Poniewierska-Baran, PhD1*, Gabriela Schneider, PhD1*, Ahmed Abdelbaset-Ismail, PhD1*, Malwina Suszynska, PhD1*, Ahmed Abdel-Latif, MD, PhD2*, Magdalena Kucia, Ph.D.3, Janina Ratajczak, MD, PhD1 and Mariusz Z Ratajczak, MD, PhD1

1Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY
2Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY
3James Graham Brown Cancer Center, Stem Cell Institute University of Louisville, Louisville, KY

Tsutomu Takahashi1*, Ritsuro Suzuki2*, Hiroyasu Ogawa, MD, PhD3, Takahiro Fukuda, MD4*, Kazuteru Ohashi5, Shuichi Taniguchi6, Yoshinobu Kanda, MD, PhD7, Hiromasa Abe8*, Yoshihisa Kodera, MD9 and Junji Suzumiya, MD, PhD1

1Department of Oncology/Hematology, Shimane University Hospital Cancer Center, Izumo, Japan
2Oncology/Haematology, Shimane University Hospital Cancer Center, Izumo, Japan
3Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan
4Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan
5Department of Hematology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan
6Department of Hematology, Toranomon Hospital, Tokyo, Japan
7Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan
8Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine, Sagamihara, Japan
9Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan

Richard S Whitmill, MBCHB FRCPath*, David J Lewis*, David John Sutton, MBBChir, MRCP, BSc*, Jahanzeb Khawaja, MB CHB MRCP*, Georgina Mayer, MB CHB MRCP*, Shankaranarayana Paneesha, MD, Emmanouil Nikolousis, PhD* and Bhuvan Kishore, MBBS, FRCPATH, MRCP*

Department of Haematology and Stem Cell Transplantation, Heart of England NHS Foundation Trust, Birmingham, United Kingdom

Yu Zhang, B.S.1*, Bin Shen, BS1*, Meng Qin, PhD1,2*, Zhihua Ren, MD, PhD1,2*, Xinxin Ding, PhD3*, Yupo Ma, MD, PhD4, Wei Dai, PhD5* and Yongping Jiang, PhD1

1Biopharmaceutical R&D Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, China
2Biopharmagen corp, Suzhou, China
3College of Nanoscale Science, SUNY Polytechnic Institute, Albany, NY
4Department of Pathology, Stony Brook University, Stony Brook, NY
5Environmental Medicine, NYU Langone Medical Center, Tuxedo, NY

Katharina Lisenko, MD1*, Thomas Bruckner, PhD2*, Michael Hundemer, MD1*, Anita Schmitt, MD3*, Joe Puthenparambil, MD1*, Petra Pavel, MD4*, Jens Hillengass, MD1, Mathias Witzens-Harig, MD5*, Hartmut Goldschmidt, MD6,7, Anthony D Ho, MD1 and Patrick Wuchter, MD1

1Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
2Institute of Medical Biometry und Informatics, Heidelberg University, Heidelberg, Germany
3Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
4Stem Cell Laboratory, IKTZ Heidelberg GmbH, Heidelberg, Germany
5Dep. Med. V, University Hospital Heidelberg, Heidelberg, Germany
6Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany
7National Center for Tumor Diseases (NCT) Heidelberg, University Hospital Heidelberg, Heidelberg, Germany

Keenan T Bashour, Ph.D.1*, Ryan P Larson, Ph.D.2*, Patricia Graef, Ph.D.3*, Christian Stemberger, Ph.D.3*, Germeroth Lothar, Ph.D.3*, Valerie Odegard, Ph.D.2* and Christopher G Ramsborg, Ph.D.1*

1Department of Process & Analytical Development, Juno Therapeutics, Inc., Seattle, WA
2Department of Translational Sciences, Juno Therapeutics, Inc., Seattle, WA
3Department of Process Development, Juno Therapeutics GmbH, Munich, Germany

Divaya Bhutani, M.D.1, Vidya sri Kondadasula2*, Joseph P. Uberti, M.D., Ph.D.1, Voravit Ratanatharathorn, M.D.1, Lawrence G. Lum, M.D., D.Sc.3, Abhinav Deol, M.D.1, Lois Ayash, M.D.1 and Muneer H. Abidi, MD4

1Division of Oncology, Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI
2Wayne State University, Detroit, MI
3Division of Hematology and Medical Oncology, Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI
4Division of stem cell transplantation, SHMG Blood & Marrow Transplant - Adult, Grand Rapids, MI

Chia-Yun Wu1*, Tzeon-Jye Chiou, MD2*, Chun-Yu Liu1*, Feng-Chang Lin3*, Jeong-Shi Lin1*, Man-Hsin Hung1*, Liang-Tsai Hsiao1*, Jyh-Pyng Gau, MD1*, Jin-Hwang Liu, MD, PhD1, Hsiu-Ju Yen4*, Giun-Yi Hung, MD5*, Hui-Chi Hsu1*, Cheng-Hwai Tzeng1*, Muh-Hwa Yang1*, Po-Min Chen1* and Yuan-Bin Yu1*

1Division of Hematology/Oncology, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan
2Division of Transfusion Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
3University of North Carolina at Chapel Hill, North Carolina, USA, North Carolina, NC
4Division of Pediatric Hematology and Oncology, Department of Pediatrics, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan
5Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan

*signifies non-member of ASH